What Researchers Did
Researchers surveyed 1628 adult females with interstitial cystitis/bladder pain syndrome (IC/BPS) to compare their perceived treatment outcomes with efficacy data from clinical trials and existing guidelines.
What They Found
Patients (n=1628) reported opioids, phenazopyridine, and alkalizing agents as most effective, with amitriptyline and antihistamines moderately effective. The only surgical procedure perceived as effective was electrocautery of Hunner's lesions, while guidelines prioritize therapies like cyclosporine A and botulinum toxin A. This indicates a general disconnect between patient perceptions of treatment success and efficacy-based guidelines.
What This Means for Canadian Patients
Canadian patients with IC/BPS may find that treatments recommended in guidelines do not always align with their personal experiences of effectiveness. This highlights the importance of shared decision-making between patients and clinicians to ensure treatment plans consider both evidence and individual patient perceptions.
Canadian Relevance
This study was published in a Canadian journal and involved Canadian researchers, directly addressing treatment effectiveness for IC/BPS, a condition affecting Canadians.
Study Limitations
A key limitation is the reliance on self-reported diagnoses and patient perceptions via a web-based survey, which may introduce recall and selection bias.